| Adam J Chamberlain, MD | |
|
329 Conway St, Greenfield, MA 01301-1521 | |
| (413) 774-6301 | |
| (866) 644-0871 |
| Full Name | Adam J Chamberlain |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 7 Years |
| Location | 329 Conway St, Greenfield, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790216976 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 271339 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Amedisys Home Health Care | Agawam, MA | Home health agency |
| Overlook Visiting Nurse Association Inc | New bedford, MA | Home health agency |
| Gvna Healthcare Inc | Gardner, MA | Home health agency |
| Hospice Of Franklin County, Inc | Greenfield, MA | Hospice |
| Baystate Franklin Medical Center | Greenfield, MA | Hospital |
| Cooley Dickinson Hospital Inc,the | Northampton, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Valley Medical Group Pc | 2365348851 | 104 |
News Archive
This achievement, which occurred in laboratory mice and is described in the March 1, 2005 issue of the Journal of Cell Science, holds great promise for victims of diseases that destroy the optic nerve, and for sufferers of central nervous system injuries.
Nathan Bryan, PH.D., one of the nation's leading experts on critically important role of nitric oxide in health and disease prevention, told attendees of the Pacific Regenerative Medicine 2017 Conference this morning that, "Stem cells are the future of medicine and are required for our body to heal itself; however, their success depends on the body producing enough nitric oxide to support their healing properties.
On the second day of high school in Texas, Natosha Daniels' 14-year-old daughter went all day without eating because she did not want to remove her mask.
Pulmonary fibrosis can possibly be attributed to a kind of cellular aging process, which is called senescence. This has been shown by researchers from the Helmholtz Zentrum München, partner in the German Center for Lung Research.
Treating advanced melanoma patients with either a combination of the immunotherapy drugs nivolumab (Opdivo™) and ipilimumab (Yervoy™) or nivolumab alone significantly increases progression-free survival (PFS) over using ipilimumab alone, according to new findings from researchers at Memorial Sloan Kettering Cancer Center (MSK) simultaneously presented today at the American Society of Clinical Oncology (ASCO) annual meeting and published online in the New England Journal of Medicine (NEJM). Examining specific characteristics of each patient's tumor has also given researchers clearer understanding of which patients should receive the combination.
› Verified 5 days ago
| Entity Name | Valley Medical Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912924705 PECOS PAC ID: 2365348851 Enrollment ID: O20031208000239 |
News Archive
This achievement, which occurred in laboratory mice and is described in the March 1, 2005 issue of the Journal of Cell Science, holds great promise for victims of diseases that destroy the optic nerve, and for sufferers of central nervous system injuries.
Nathan Bryan, PH.D., one of the nation's leading experts on critically important role of nitric oxide in health and disease prevention, told attendees of the Pacific Regenerative Medicine 2017 Conference this morning that, "Stem cells are the future of medicine and are required for our body to heal itself; however, their success depends on the body producing enough nitric oxide to support their healing properties.
On the second day of high school in Texas, Natosha Daniels' 14-year-old daughter went all day without eating because she did not want to remove her mask.
Pulmonary fibrosis can possibly be attributed to a kind of cellular aging process, which is called senescence. This has been shown by researchers from the Helmholtz Zentrum München, partner in the German Center for Lung Research.
Treating advanced melanoma patients with either a combination of the immunotherapy drugs nivolumab (Opdivo™) and ipilimumab (Yervoy™) or nivolumab alone significantly increases progression-free survival (PFS) over using ipilimumab alone, according to new findings from researchers at Memorial Sloan Kettering Cancer Center (MSK) simultaneously presented today at the American Society of Clinical Oncology (ASCO) annual meeting and published online in the New England Journal of Medicine (NEJM). Examining specific characteristics of each patient's tumor has also given researchers clearer understanding of which patients should receive the combination.
› Verified 5 days ago
| Entity Name | Behavioral Health Network Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477582609 PECOS PAC ID: 3072596360 Enrollment ID: O20040608001373 |
News Archive
This achievement, which occurred in laboratory mice and is described in the March 1, 2005 issue of the Journal of Cell Science, holds great promise for victims of diseases that destroy the optic nerve, and for sufferers of central nervous system injuries.
Nathan Bryan, PH.D., one of the nation's leading experts on critically important role of nitric oxide in health and disease prevention, told attendees of the Pacific Regenerative Medicine 2017 Conference this morning that, "Stem cells are the future of medicine and are required for our body to heal itself; however, their success depends on the body producing enough nitric oxide to support their healing properties.
On the second day of high school in Texas, Natosha Daniels' 14-year-old daughter went all day without eating because she did not want to remove her mask.
Pulmonary fibrosis can possibly be attributed to a kind of cellular aging process, which is called senescence. This has been shown by researchers from the Helmholtz Zentrum München, partner in the German Center for Lung Research.
Treating advanced melanoma patients with either a combination of the immunotherapy drugs nivolumab (Opdivo™) and ipilimumab (Yervoy™) or nivolumab alone significantly increases progression-free survival (PFS) over using ipilimumab alone, according to new findings from researchers at Memorial Sloan Kettering Cancer Center (MSK) simultaneously presented today at the American Society of Clinical Oncology (ASCO) annual meeting and published online in the New England Journal of Medicine (NEJM). Examining specific characteristics of each patient's tumor has also given researchers clearer understanding of which patients should receive the combination.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Adam J Chamberlain, MD 329 Conway St, Greenfield, MA 01301-1521 Ph: (413) 774-6301 | Adam J Chamberlain, MD 329 Conway St, Greenfield, MA 01301-1521 Ph: (413) 774-6301 |
News Archive
This achievement, which occurred in laboratory mice and is described in the March 1, 2005 issue of the Journal of Cell Science, holds great promise for victims of diseases that destroy the optic nerve, and for sufferers of central nervous system injuries.
Nathan Bryan, PH.D., one of the nation's leading experts on critically important role of nitric oxide in health and disease prevention, told attendees of the Pacific Regenerative Medicine 2017 Conference this morning that, "Stem cells are the future of medicine and are required for our body to heal itself; however, their success depends on the body producing enough nitric oxide to support their healing properties.
On the second day of high school in Texas, Natosha Daniels' 14-year-old daughter went all day without eating because she did not want to remove her mask.
Pulmonary fibrosis can possibly be attributed to a kind of cellular aging process, which is called senescence. This has been shown by researchers from the Helmholtz Zentrum München, partner in the German Center for Lung Research.
Treating advanced melanoma patients with either a combination of the immunotherapy drugs nivolumab (Opdivo™) and ipilimumab (Yervoy™) or nivolumab alone significantly increases progression-free survival (PFS) over using ipilimumab alone, according to new findings from researchers at Memorial Sloan Kettering Cancer Center (MSK) simultaneously presented today at the American Society of Clinical Oncology (ASCO) annual meeting and published online in the New England Journal of Medicine (NEJM). Examining specific characteristics of each patient's tumor has also given researchers clearer understanding of which patients should receive the combination.
› Verified 5 days ago
Franklin R Thomas, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 489 Bernardston Rd Ste 108, Greenfield, MA 01301 Phone: 413-325-8500 | |
Peter Brooks Koppenheffer, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 48 Sanderson St, Greenfield, MA 01301 Phone: 413-773-2022 | |
Dr. Patricia A Iverson, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 329 Conway St, Valley Medical Group, Pc-greenfield Health Center, Greenfield, MA 01301 Phone: 413-774-6301 Fax: 866-644-0871 | |
Dr. Sara A Rourke, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 48 Sanderson St, Greenfield, MA 01301 Phone: 413-773-2022 Fax: 413-773-4945 | |
Sherry H Weitzen, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 48 Sanderson St, Greenfield, MA 01301 Phone: 413-773-2778 Fax: 413-773-4945 | |
Margit Lisa Walker, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 329 Conway St, Greenfield Health Center, Greenfield, MA 01301 Phone: 413-774-6301 Fax: 413-772-3314 | |
Dr. Jennifer Elizabeth Madden, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 48 Sanderson St, Greenfield, MA 01301 Phone: 413-773-2022 Fax: 413-773-4945 |